0001562180-20-000897.txt : 20200205
0001562180-20-000897.hdr.sgml : 20200205
20200205172821
ACCESSION NUMBER: 0001562180-20-000897
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200203
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lehman David Aaron
CENTRAL INDEX KEY: 0001354228
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 20579872
MAIL ADDRESS:
STREET 1: 6035 STONERIDGE DRIVE
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-02-03
false
0001271214
Intersect ENT, Inc.
XENT
0001354228
Lehman David Aaron
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
EVP & General Counsel
Common Stock
2020-02-03
4
A
false
10740.00
0.00
A
68465.00
D
Common Stock
2020-02-03
4
A
false
10740.00
0.00
A
79205.00
D
Stock Options (Right to buy)
26.18
2020-02-03
4
A
false
21270.00
0.00
A
2030-02-03
Common Stock
21270.00
21270.00
D
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets.
Includes 51,034 restricted stock units, of which 42,534 are performance based.
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date.
Includes 61,774 restricted stock units, of which 42,534 are performance based.
The vesting commencement date of the option is February 3, 2020. 1/8th of the shares subject to the option shall vest on August 3, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.
/s/ David A. Lehman
2020-02-05